Sonja Alsemgeest Swanson, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mendelian Randomization Analysis | 19 | 2024 | 1044 | 5.920 |
Why?
|
Causality | 14 | 2024 | 1248 | 3.490 |
Why?
|
Firearms | 9 | 2024 | 630 | 2.550 |
Why?
|
Suicide | 11 | 2024 | 1604 | 1.880 |
Why?
|
Data Interpretation, Statistical | 10 | 2024 | 2686 | 1.320 |
Why?
|
Dementia | 5 | 2024 | 2744 | 1.170 |
Why?
|
Binge-Eating Disorder | 10 | 2018 | 157 | 0.990 |
Why?
|
Bulimia Nervosa | 13 | 2018 | 208 | 0.950 |
Why?
|
Selection Bias | 4 | 2024 | 361 | 0.890 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2023 | 2531 | 0.830 |
Why?
|
Epidemiologic Methods | 2 | 2019 | 1326 | 0.810 |
Why?
|
Anemia | 2 | 2025 | 1511 | 0.600 |
Why?
|
Models, Statistical | 8 | 2024 | 5089 | 0.590 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 9 | 2016 | 1989 | 0.560 |
Why?
|
Pregnancy Outcome | 4 | 2025 | 2966 | 0.550 |
Why?
|
Bulimia | 5 | 2016 | 404 | 0.530 |
Why?
|
Sigmoidoscopy | 1 | 2015 | 150 | 0.480 |
Why?
|
Epidemiologic Research Design | 2 | 2021 | 368 | 0.480 |
Why?
|
Humans | 115 | 2025 | 765968 | 0.430 |
Why?
|
Antidepressive Agents | 5 | 2016 | 2897 | 0.410 |
Why?
|
Comparative Effectiveness Research | 2 | 2015 | 714 | 0.410 |
Why?
|
Genetic Variation | 5 | 2021 | 6610 | 0.400 |
Why?
|
Dietary Supplements | 2 | 2025 | 3425 | 0.400 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.390 |
Why?
|
Statistics as Topic | 2 | 2015 | 2352 | 0.390 |
Why?
|
Interview, Psychological | 7 | 2015 | 812 | 0.380 |
Why?
|
Smoking Cessation | 1 | 2023 | 2084 | 0.370 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2013 | 318 | 0.360 |
Why?
|
Ownership | 3 | 2024 | 338 | 0.360 |
Why?
|
Body Image | 4 | 2017 | 644 | 0.360 |
Why?
|
Psychiatric Status Rating Scales | 9 | 2016 | 6014 | 0.350 |
Why?
|
Research Report | 1 | 2013 | 367 | 0.330 |
Why?
|
Self-Injurious Behavior | 6 | 2016 | 570 | 0.330 |
Why?
|
Probability | 3 | 2024 | 2475 | 0.320 |
Why?
|
Pregnancy Complications | 3 | 2022 | 2975 | 0.320 |
Why?
|
Emigration and Immigration | 1 | 2011 | 405 | 0.300 |
Why?
|
Body Weight | 8 | 2017 | 4622 | 0.300 |
Why?
|
Anorexia Nervosa | 9 | 2018 | 1328 | 0.300 |
Why?
|
Anxiety Disorders | 7 | 2016 | 2737 | 0.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3251 | 0.290 |
Why?
|
Female | 71 | 2025 | 396112 | 0.290 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 3719 | 0.280 |
Why?
|
Public Health | 1 | 2021 | 2680 | 0.280 |
Why?
|
Monte Carlo Method | 2 | 2016 | 1238 | 0.280 |
Why?
|
Gastrointestinal Diseases | 2 | 2013 | 1203 | 0.280 |
Why?
|
California | 4 | 2024 | 1436 | 0.270 |
Why?
|
Prevalence | 12 | 2020 | 15842 | 0.270 |
Why?
|
Adolescent | 36 | 2025 | 88835 | 0.270 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2023 | 10383 | 0.270 |
Why?
|
Epidemiology | 2 | 2021 | 279 | 0.260 |
Why?
|
Botswana | 3 | 2025 | 1057 | 0.260 |
Why?
|
Pregnancy | 11 | 2025 | 30260 | 0.250 |
Why?
|
Cohort Studies | 17 | 2024 | 41649 | 0.250 |
Why?
|
Substance-Related Disorders | 9 | 2016 | 4416 | 0.250 |
Why?
|
Depression | 6 | 2016 | 8237 | 0.250 |
Why?
|
Research Design | 5 | 2024 | 6209 | 0.240 |
Why?
|
Guidelines as Topic | 2 | 2021 | 1394 | 0.240 |
Why?
|
Pandemics | 2 | 2022 | 8703 | 0.240 |
Why?
|
Mood Disorders | 3 | 2012 | 1128 | 0.240 |
Why?
|
Blood Pressure | 1 | 2020 | 8532 | 0.240 |
Why?
|
Mental Disorders | 7 | 2015 | 6853 | 0.240 |
Why?
|
Homicide | 2 | 2024 | 293 | 0.230 |
Why?
|
Longitudinal Studies | 13 | 2023 | 14751 | 0.230 |
Why?
|
Suicide, Attempted | 4 | 2015 | 1409 | 0.230 |
Why?
|
Micronutrients | 2 | 2025 | 390 | 0.230 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6544 | 0.210 |
Why?
|
Self Report | 2 | 2017 | 3770 | 0.210 |
Why?
|
Stroke | 3 | 2020 | 9747 | 0.210 |
Why?
|
Male | 57 | 2024 | 363698 | 0.210 |
Why?
|
Hyperphagia | 2 | 2014 | 139 | 0.210 |
Why?
|
Hypertension | 2 | 2020 | 8626 | 0.210 |
Why?
|
Sex | 1 | 2022 | 53 | 0.210 |
Why?
|
Law Enforcement | 1 | 2024 | 112 | 0.200 |
Why?
|
Medicaid | 1 | 2015 | 2833 | 0.190 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2015 | 490 | 0.190 |
Why?
|
Trans Fatty Acids | 1 | 2022 | 155 | 0.180 |
Why?
|
Premature Birth | 2 | 2025 | 1829 | 0.180 |
Why?
|
Communication | 1 | 2015 | 3916 | 0.180 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3236 | 0.180 |
Why?
|
HIV Infections | 2 | 2025 | 17533 | 0.180 |
Why?
|
Parents | 2 | 2016 | 3592 | 0.180 |
Why?
|
Folic Acid | 2 | 2025 | 1338 | 0.180 |
Why?
|
Pleural Effusion, Malignant | 2 | 1998 | 109 | 0.170 |
Why?
|
Young Adult | 22 | 2025 | 59889 | 0.170 |
Why?
|
Registries | 1 | 2016 | 8297 | 0.170 |
Why?
|
Policy | 1 | 2023 | 511 | 0.160 |
Why?
|
Cholesterol, HDL | 2 | 2023 | 1811 | 0.160 |
Why?
|
Erythrocyte Transfusion | 1 | 2024 | 568 | 0.160 |
Why?
|
Comorbidity | 9 | 2017 | 10563 | 0.160 |
Why?
|
Iron | 2 | 2025 | 1816 | 0.160 |
Why?
|
Drug Repositioning | 1 | 2021 | 246 | 0.150 |
Why?
|
Adult | 35 | 2025 | 223044 | 0.150 |
Why?
|
Myocardial Infarction | 2 | 2024 | 11499 | 0.150 |
Why?
|
Aged, 80 and over | 14 | 2020 | 59489 | 0.150 |
Why?
|
Hemoglobins | 1 | 2024 | 1530 | 0.150 |
Why?
|
Wounds, Gunshot | 1 | 2024 | 585 | 0.150 |
Why?
|
Middle Aged | 29 | 2024 | 223009 | 0.150 |
Why?
|
United States | 19 | 2024 | 72903 | 0.150 |
Why?
|
Venules | 1 | 2018 | 162 | 0.150 |
Why?
|
Suicidal Ideation | 3 | 2014 | 1461 | 0.150 |
Why?
|
Adolescent Behavior | 3 | 2016 | 1185 | 0.150 |
Why?
|
Goals | 1 | 2023 | 719 | 0.150 |
Why?
|
Child | 21 | 2023 | 80564 | 0.150 |
Why?
|
Neoplasms | 2 | 2024 | 22340 | 0.140 |
Why?
|
Ascitic Fluid | 1 | 1997 | 190 | 0.140 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 786 | 0.140 |
Why?
|
Risk Factors | 14 | 2023 | 74840 | 0.140 |
Why?
|
Databases as Topic | 1 | 2019 | 471 | 0.140 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 416 | 0.140 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 12807 | 0.130 |
Why?
|
Reference Standards | 1 | 2019 | 1013 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6942 | 0.130 |
Why?
|
Biomedical Research | 1 | 2011 | 3458 | 0.130 |
Why?
|
Pericardial Effusion | 1 | 1997 | 246 | 0.120 |
Why?
|
Aged | 17 | 2024 | 171117 | 0.120 |
Why?
|
Surrogate Mothers | 1 | 2014 | 16 | 0.120 |
Why?
|
Paroxetine | 1 | 2015 | 180 | 0.120 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 307 | 0.120 |
Why?
|
Age Factors | 9 | 2019 | 18380 | 0.120 |
Why?
|
Body Size | 1 | 2017 | 459 | 0.120 |
Why?
|
Pleural Effusion | 1 | 1997 | 346 | 0.120 |
Why?
|
Checklist | 1 | 2021 | 848 | 0.110 |
Why?
|
Norway | 1 | 2015 | 499 | 0.110 |
Why?
|
Smoking | 2 | 2023 | 9081 | 0.110 |
Why?
|
Health Surveys | 6 | 2014 | 4056 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1123 | 0.110 |
Why?
|
Cholesterol | 1 | 2023 | 2898 | 0.110 |
Why?
|
Mastication | 1 | 2013 | 53 | 0.110 |
Why?
|
Health Services Needs and Demand | 2 | 2019 | 1406 | 0.110 |
Why?
|
Pregnancy Rate | 2 | 2014 | 655 | 0.110 |
Why?
|
Travel | 1 | 2019 | 806 | 0.110 |
Why?
|
Data Collection | 1 | 2022 | 3318 | 0.110 |
Why?
|
Drug Labeling | 1 | 2015 | 250 | 0.110 |
Why?
|
Health Status Disparities | 1 | 2025 | 1880 | 0.100 |
Why?
|
Personal Satisfaction | 1 | 2017 | 641 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2025 | 2187 | 0.100 |
Why?
|
DNA Fragmentation | 1 | 2013 | 238 | 0.100 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2014 | 187 | 0.100 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2013 | 156 | 0.100 |
Why?
|
Feeding Behavior | 3 | 2013 | 3212 | 0.100 |
Why?
|
Diagnostic Self Evaluation | 1 | 2014 | 228 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2025 | 26346 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1462 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2024 | 4040 | 0.090 |
Why?
|
Cross-Sectional Studies | 6 | 2017 | 26318 | 0.090 |
Why?
|
Computer Simulation | 1 | 2024 | 6255 | 0.090 |
Why?
|
Risk Assessment | 6 | 2018 | 24282 | 0.090 |
Why?
|
Adenocarcinoma | 2 | 1998 | 6364 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 1998 | 1050 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2023 | 3615 | 0.090 |
Why?
|
Time Factors | 3 | 2019 | 40065 | 0.090 |
Why?
|
Propensity Score | 2 | 2015 | 1968 | 0.090 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2014 | 501 | 0.080 |
Why?
|
Mental Health Services | 2 | 2012 | 1723 | 0.080 |
Why?
|
Epidemiologic Studies | 1 | 2013 | 677 | 0.080 |
Why?
|
Body Mass Index | 5 | 2016 | 13039 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1441 | 0.080 |
Why?
|
Infertility, Male | 1 | 2013 | 395 | 0.080 |
Why?
|
Obesity | 4 | 2019 | 13076 | 0.080 |
Why?
|
Drug Prescriptions | 2 | 2016 | 1662 | 0.080 |
Why?
|
Mental Competency | 1 | 2010 | 179 | 0.080 |
Why?
|
Anorexia | 1 | 2010 | 153 | 0.080 |
Why?
|
Granulosa Cell Tumor | 1 | 1990 | 71 | 0.080 |
Why?
|
Mexico | 1 | 2011 | 777 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2268 | 0.080 |
Why?
|
Depressive Disorder | 4 | 2015 | 3714 | 0.080 |
Why?
|
Spermatozoa | 1 | 2013 | 629 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3432 | 0.070 |
Why?
|
Netherlands | 3 | 2019 | 2277 | 0.070 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39193 | 0.070 |
Why?
|
Eating | 2 | 2013 | 1540 | 0.070 |
Why?
|
Prospective Studies | 10 | 2022 | 54802 | 0.070 |
Why?
|
Sex Factors | 4 | 2019 | 10603 | 0.070 |
Why?
|
Canada | 1 | 2013 | 2119 | 0.070 |
Why?
|
Patient Selection | 2 | 2019 | 4255 | 0.070 |
Why?
|
Heart Diseases | 1 | 2020 | 2821 | 0.070 |
Why?
|
Molecular Epidemiology | 1 | 2010 | 471 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 1997 | 1661 | 0.070 |
Why?
|
Child Development | 1 | 2019 | 2327 | 0.070 |
Why?
|
Anthropometry | 1 | 2012 | 1338 | 0.070 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 634 | 0.070 |
Why?
|
Age of Onset | 2 | 2011 | 3344 | 0.070 |
Why?
|
Long-Term Care | 1 | 2010 | 629 | 0.070 |
Why?
|
Pilot Projects | 2 | 2021 | 8733 | 0.070 |
Why?
|
Research Personnel | 2 | 2023 | 590 | 0.060 |
Why?
|
Educational Status | 1 | 2014 | 2513 | 0.060 |
Why?
|
Incidence | 3 | 2020 | 21480 | 0.060 |
Why?
|
Craniocerebral Trauma | 1 | 2010 | 494 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12056 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2017 | 65188 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2018 | 3000 | 0.060 |
Why?
|
Cause of Death | 4 | 2020 | 3708 | 0.060 |
Why?
|
Child Abuse | 1 | 2013 | 1090 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2013 | 14652 | 0.060 |
Why?
|
Body Composition | 1 | 2014 | 2439 | 0.060 |
Why?
|
Respiratory Tract Diseases | 1 | 2010 | 744 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8041 | 0.060 |
Why?
|
Medication Adherence | 1 | 2016 | 2192 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 16047 | 0.050 |
Why?
|
Chronic Disease | 1 | 2018 | 9347 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15398 | 0.050 |
Why?
|
Severity of Illness Index | 7 | 2016 | 15880 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15652 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2015 | 2041 | 0.050 |
Why?
|
Headache | 1 | 2011 | 1259 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1997 | 4044 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5508 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3076 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2011 | 2415 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13632 | 0.050 |
Why?
|
Interleukin-10 Receptor beta Subunit | 1 | 2021 | 16 | 0.050 |
Why?
|
Weight Gain | 1 | 2011 | 2355 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2021 | 113 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2010 | 1168 | 0.040 |
Why?
|
Interviews as Topic | 3 | 2013 | 2739 | 0.040 |
Why?
|
Researcher-Subject Relations | 1 | 2018 | 14 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4808 | 0.040 |
Why?
|
Receptors, Neuropeptide Y | 1 | 1997 | 47 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2019 | 504 | 0.040 |
Why?
|
Risk | 3 | 2015 | 9591 | 0.040 |
Why?
|
Prognosis | 2 | 2015 | 29922 | 0.030 |
Why?
|
Universities | 1 | 2022 | 998 | 0.030 |
Why?
|
Physicians | 1 | 2015 | 4588 | 0.030 |
Why?
|
Migraine Disorders | 1 | 2010 | 1732 | 0.030 |
Why?
|
Overweight | 3 | 2013 | 2444 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5891 | 0.030 |
Why?
|
Stillbirth | 1 | 2019 | 381 | 0.030 |
Why?
|
Affective Symptoms | 1 | 2019 | 417 | 0.030 |
Why?
|
DNA | 1 | 1990 | 7202 | 0.030 |
Why?
|
Population | 1 | 2016 | 140 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10070 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2013 | 4628 | 0.030 |
Why?
|
Child, Preschool | 5 | 2019 | 42500 | 0.030 |
Why?
|
Fetus | 1 | 2022 | 1870 | 0.030 |
Why?
|
Age Distribution | 2 | 2011 | 2858 | 0.030 |
Why?
|
Contracts | 1 | 2014 | 60 | 0.030 |
Why?
|
Sertraline | 1 | 2015 | 209 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30198 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 834 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13451 | 0.030 |
Why?
|
Intelligence | 1 | 2019 | 923 | 0.030 |
Why?
|
Ontario | 1 | 2014 | 402 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2016 | 81514 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3202 | 0.030 |
Why?
|
Birth Rate | 1 | 2014 | 169 | 0.030 |
Why?
|
Phenotype | 1 | 2011 | 16721 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1142 | 0.030 |
Why?
|
New Zealand | 1 | 2013 | 359 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 1990 | 4900 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 22223 | 0.030 |
Why?
|
Hospitals, University | 1 | 2014 | 574 | 0.030 |
Why?
|
Citalopram | 1 | 2015 | 402 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2140 | 0.030 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2014 | 394 | 0.030 |
Why?
|
Students | 1 | 2022 | 1734 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 647 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2393 | 0.020 |
Why?
|
Pleural Neoplasms | 1 | 1997 | 581 | 0.020 |
Why?
|
Recurrence | 1 | 2024 | 8501 | 0.020 |
Why?
|
Health Services Research | 1 | 2019 | 1808 | 0.020 |
Why?
|
Fluoxetine | 1 | 2015 | 729 | 0.020 |
Why?
|
Health Policy | 1 | 2024 | 2698 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27171 | 0.020 |
Why?
|
Telemedicine | 1 | 2009 | 3105 | 0.020 |
Why?
|
Psychopathology | 1 | 2014 | 435 | 0.020 |
Why?
|
Mesothelioma | 1 | 1997 | 771 | 0.020 |
Why?
|
Minnesota | 1 | 2011 | 336 | 0.020 |
Why?
|
Patient Preference | 1 | 2018 | 952 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2014 | 20124 | 0.020 |
Why?
|
Migraine without Aura | 1 | 2011 | 81 | 0.020 |
Why?
|
Pneumonectomy | 1 | 1997 | 1128 | 0.020 |
Why?
|
Alcohol-Related Disorders | 1 | 2012 | 242 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13266 | 0.020 |
Why?
|
Indoles | 1 | 1997 | 1839 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2590 | 0.020 |
Why?
|
Parenting | 1 | 2014 | 709 | 0.020 |
Why?
|
Migraine with Aura | 1 | 2011 | 204 | 0.020 |
Why?
|
Attention | 1 | 2019 | 2419 | 0.020 |
Why?
|
Personality Assessment | 1 | 2010 | 646 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3278 | 0.020 |
Why?
|
Vomiting | 1 | 2011 | 647 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7425 | 0.020 |
Why?
|
Psychology | 1 | 2010 | 354 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3564 | 0.020 |
Why?
|
Social Adjustment | 1 | 2010 | 633 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10729 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1672 | 0.020 |
Why?
|
Counseling | 1 | 2014 | 1551 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2010 | 7838 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2263 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2033 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 968 | 0.020 |
Why?
|
Aneuploidy | 1 | 1990 | 578 | 0.020 |
Why?
|
Motivation | 1 | 2016 | 2018 | 0.020 |
Why?
|
Epithelial Cells | 1 | 1997 | 3681 | 0.020 |
Why?
|
Body Height | 1 | 2012 | 1562 | 0.020 |
Why?
|
Microscopy | 1 | 1990 | 901 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2334 | 0.010 |
Why?
|
Diet | 1 | 2022 | 8086 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3925 | 0.010 |
Why?
|
Survival Rate | 1 | 1998 | 12795 | 0.010 |
Why?
|
Psychometrics | 1 | 2013 | 3062 | 0.010 |
Why?
|
Infant | 2 | 2019 | 36386 | 0.010 |
Why?
|
Cell Division | 1 | 1990 | 4475 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9649 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12509 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8067 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5876 | 0.010 |
Why?
|
Alcoholism | 1 | 2010 | 1975 | 0.010 |
Why?
|
Flow Cytometry | 1 | 1990 | 5881 | 0.010 |
Why?
|
Cost of Illness | 1 | 2009 | 1950 | 0.010 |
Why?
|
Mortality | 1 | 2009 | 2904 | 0.010 |
Why?
|
Sleep | 1 | 2014 | 4813 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1997 | 364 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 5526 | 0.010 |
Why?
|
Health Care Costs | 1 | 2009 | 3242 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3413 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12976 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1997 | 3051 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1997 | 9373 | 0.000 |
Why?
|
Mice | 1 | 1997 | 81819 | 0.000 |
Why?
|
Animals | 1 | 1997 | 168764 | 0.000 |
Why?
|